|
| Status |
Public on Aug 17, 2017 |
| Title |
Primary_Tumor 6069 |
| Sample type |
RNA |
| |
|
| Source name |
Tissue samples taken from colorectal cancer patients
|
| Organism |
Homo sapiens |
| Characteristics |
center: Toulouse
Sex: Male
age: 68
who performance status: 1
tumor location: Left colon
synchronous metastase: Yes
pn: pN0
pt: pT3
regimen: FOLFIRI+BEVACIZUMAB
response category: PR
response status: R
pfs censored: 1
pfs: 18.16837692
os censored: 0
os: 60.28747559
|
| Treatment protocol |
Samples were collected before chemotherapy
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Rneasy kit (Qiagen) for total RNA was performed according to the manufacturer's instructions.
|
| Label |
biotin
|
| Label protocol |
Biotinylated cRNA were prepared according to the Affymetrix protocol.
|
| |
|
| Hybridization protocol |
Following fragmentation, cRNA were hybridized on GeneChip Human Genome U133 Plus 2.0 array.
|
| Scan protocol |
GeneChips were scanned using a laser scanner.
|
| Data processing |
Processing and normalization was done using the Robust Multi-array Average (RMA)
|
| |
|
| Submission date |
Sep 12, 2015 |
| Last update date |
Aug 17, 2017 |
| Contact name |
Pierre Martineau |
| E-mail(s) |
pierre.martineau@inserm.fr
|
| Phone |
+33 4 67 61 37 43
|
| Organization name |
Inserm
|
| Department |
IRCM
|
| Street address |
208 Rue des Apothicaires
|
| City |
Montpellier Cedex 5 |
| ZIP/Postal code |
34298 |
| Country |
France |
| |
|
| Platform ID |
GPL570 |
| Series (2) |
| GSE72969 |
Molecular subtypes of metastatic colorectal cancer are predictive of patient response to chemo and targeted therapies (part 2) |
| GSE72970 |
Molecular subtypes of metastatic colorectal cancer are predictive of patient response to chemo and targeted therapies |
|
